ABEO

Insider trade Sale by Alvino Mark

10d ago

Insider trade Sale by Crombez Eric

17d ago

SEC filing ABEO Reports $8.7M Revenue, $0.30 Loss per Share in Q1 2026

20d ago

Insider trade Sale by Madhav Vasanthavada (Chief Commercial Officer)

21d ago

Short interest Short interest 27.8% of float

38d ago

News Abeona targets activation of 7 QTCs for ZEVASKYN by end of 2026 as patient demand doubles

76d ago

SEC filing ABEO Reports $5.8M Revenue, $71.2M Net Income, $191.4M Cash, Launches ZEVASKYN Commercial Treatment

77d ago

Insider trade Sale by Joseph Walter Vazzano (Chief Financial Officer)

77d ago

Insider trade Sale by Christine Berni Silverstein

104d ago

Insider trade Sale by Mark Alvino

104d ago

Insider trade Sale by Leila Alland

104d ago

Insider trade Sale by Mark Alvino

104d ago

Insider trade Sale by Joseph Walter Vazzano

104d ago

Insider trade Sale by Vishwas Seshadri

104d ago

Insider trade Sale by Brendan M. O'Malley

104d ago

Insider trade Sale by Eric Crombez

104d ago

Insider trade Sale by Madhav Vasanthavada

104d ago

Insider trade Sale by Donald A. Wuchterl

104d ago

Failures to deliver 552,617 shares failed to deliver

152d ago

News Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

153d ago

Failures to deliver 552,617 shares failed to deliver

160d ago

Failures to deliver 552,617 shares failed to deliver

169d ago